License and supply agreement with Genuine Health
RNS & Investor News
Exercise of warrants and issue of equity
18 July 2014
The Company has received notifications from warrant holders to exercise warrants over 2,288,482 ordinary shares in the Company, consequently the Company issued and allotted 2,288,482 ordinary shares in the Company.
Application has been made to the London Stock Exchange for the 2,288,482 ordinary shares to be admitted to trading on AIM. The 2,288,482 ordinary shares will rank pari passu with the existing ordinary shares. Admission to trading of the 2,288,482 ordinary shares is expected to occur on or around 25 July 2014.
Following admission of the 2,288,482 ordinary shares the Company will have a total of 1,100,906,719 shares admitted to trading on AIM.
Total Voting Rights
The Company's issued share capital consists of 1,100,906,719 ordinary shares. The Company holds no shares in treasury; therefore, the total number of voting rights in the Company is 1,100,906,719.
The figure of 1,100,906,719 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information, please contact:
|Ducat Ventures plc||Nicholas Nelson||+44 (0)79 2152 2920|
|Cairn Financial Advisers LLP||Liam Murray / Jo Turner||+44 (0)20 7148 7900|
|Peterhouse Corporate Finance Ltd||Lucy Williams/ Fungai Ndoro||+44 (0)20 7469 0936|
OptiBiotix Health secures significant exclusive licence agreement for OptiBiome
Stephen O'Hara | 01 Apr 2020